Soligenix Files Proxy Statement
Ticker: SNGX · Form: DEFA14A · Filed: May 28, 2024 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | DEFA14A |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, sec-filing, corporate-governance
Related Tickers: SOLI
TL;DR
SOLI proxy filing dropped, shareholders vote soon.
AI Summary
Soligenix, Inc. filed a Definitive Additional Materials proxy statement on May 28, 2024. This filing relates to the company's solicitation of proxies for its upcoming shareholder meeting. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing is a routine procedural document that allows shareholders to vote on company matters, impacting corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — This is a standard proxy filing, not indicating any immediate financial or operational risk.
Key Players & Entities
- SOLIGENIX, INC. (company) — Registrant
- 0001558370-24-008676 (filing_id) — Accession Number
- 20240528 (date) — Filing Date
- 2834 (sic_code) — Standard Industrial Classification (Pharmaceutical Preparations)
- DE (state) — State of Incorporation
- 1231 (fiscal_year_end) — Fiscal Year End
- DEFA14A (form_type) — SEC Filing Type
- 001-14778 (sec_file_number) — SEC File Number
- 24991829 (film_number) — Film Number
- 29 EMMONS DRIVE (street_address) — Business Address
FAQ
What type of SEC filing is this?
This is a DEFA14A, a Definitive Additional Materials proxy statement.
Who is the filing company?
The filing company is SOLIGENIX, INC.
When was this filing made?
The filing was made on May 28, 2024.
What is Soligenix, Inc.'s Standard Industrial Classification code?
Soligenix, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Soligenix, Inc. incorporated?
Soligenix, Inc. is incorporated in Delaware (DE).
Filing Stats: 167 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-05-28 16:08:23
Filing Documents
- tmb-20240528xdefa14a.htm (DEFA14A) — 10KB
- 0001558370-24-008676.txt ( ) — 12KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement. Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement. Definitive Additional Materials. Soliciting Material Pursuant to 240.14a-12 SOLIGENIX, INC. (Name of Registrant as Specified in Its Charter) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. [The following is a post made to the Company's social media pages on Twitter, Facebook, Instagram and LinkedIn on May 28, 2024] LAST 2 DAYS TO VOTE! Participate in our Annual Meeting of Shareholders. Go to www.proxyvote.com or call 1-800-690-6903 (have your proxy card available) to vote. If you do NOT have your proxy card available, call our proxy solicitor, Alliance Advisors at 1-833-782-7145.